WHO convenes experts to identify new pathogens that could spark pandemics

WHO convenes experts to identify new pathogens that could spark pandemics
0 0
Read Time:1 Minute, 34 Second

A health worker trains at an isolation centre in Bole Chefe, near Addis Ababa, Ethiopia.
© WHO/Otto Bakano A health worker trains at an isolation centre in Bole Chefe, near Addis Ababa, Ethiopia.

Health

The World Health Organization (WHO) is working to compile an updated list of priority pathogens that can cause future outbreaks or pandemics, the UN agency announced on Monday.

WHO is convening over 300 scientists who will consider the evidence on over 25 virus families and bacteria, as well as “Disease X”, which indicates an unknown pathogen that could cause a serious international epidemic.

The process began on Friday and will guide global investment, and research and development (R&D), especially in vaccines, tests, and treatments.

Essential for quick response

The priority pathogens list was first published in 2017 and includes COVID-19, Ebola virus disease, Lassa fever, Middle East respiratory syndrome (MERS), Severe Acute Respiratory Syndrome (SARS), Rift Valley fever, Zika, and “Disease X”.

“Targeting priority pathogens and virus families for research and development of countermeasures is essential for a fast and effective epidemic and pandemic response”, said Dr. Michael Ryan, Executive Director of WHO’s Health Emergencies Programme.

“Without significant R&D investments prior to the COVID-19 pandemic, it would not have been possible to have safe and effective vaccines developed in record time”, he added.

Roadmap for research

The experts will recommend a list of priority pathogens that need further research and investment.

The process will include both scientific and public health criteria, as well as criteria related to socioeconomic impact, access, and equity.

R&D roadmaps will be developed for those pathogens identified as priority, laying out knowledge gaps and areas for research.

Desired specifications for vaccines, treatments and diagnostic tests will also be determined, where relevant.

Efforts will also be made to map, compile and facilitate clinical trials to develop these tools.

The revised list is expected to be published in early 2023.

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

About The Author

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

  1. Thanks for the thoughts you are revealing on this web site. Another thing I'd prefer to say is getting hold…

Advertise With Us to Help us Grow

error: Content is protected !!